voriconazole,posaconazole,ravaconazole.
综述了三唑类抗真菌药的最新研究进展,介绍了伏立康唑、泊沙康唑、ravaconazole 3个新药物,与其他抗真菌药比较,均显示了其优点。
In recent years,some novel antifungal agents have been developed,including new azoles such as vorriconazole and posaconazole,and echinocandins such as caspofungin and micafungin.
近年来,一些新的抗真菌药物相继问世,包括新三唑类(活力康唑、泊沙康唑等)和棘白菌素类(卡泊芬净、米卡芬净等)。
In vitro and in vivo studies showed that posaconazole has broad-spectrum activity against most Candida species,Cryptococcus neoformans,Aspergillus species,Fusarium species,zygomycetes,and endemic fungi.
泊沙康唑为一新型三唑类抗真菌药,用于治疗和预防侵袭性真菌感染。